Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Vittecoq

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Vox Sanguinis|January 1, 1997
Virological and immunological data of AIDS patients treated by passive immunotherapy (transfusions of plasma rich in HIV-1 antibodies)L Morand-Joubert, D Vittecoq, F Roudot-Thoraval, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2000
The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues. Study of Protease Inhibitor Combinations in EuropeG Moyle, A Pozniak, M Opravil, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 4, 2015
Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipientsB Wyplosz, O Derradji, E Hong, et al.
Medecine Et Maladies Infectieuses|December 30, 2008
[Vaccinations for the traveling adult solid organ transplant recipient (excluding hematopoietic stem cell transplant recipients)]B Wyplosz, D Van der Vliet, P H Consigny, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2000
Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipientP Sellier, J J Monsuez, C Lacroix, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 10, 2013
Persistence of yellow fever vaccine-induced antibodies after solid organ transplantationB Wyplosz, C Burdet, H François, et al.
The Journal of Hospital Infection|February 26, 2018
Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative studyA Dinh, H Fessi, C Duran, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 21, 2015
Infectious complications after liver transplantation in human immunodeficiency virus-infected recipientsE Teicher, F Boufassa, D Vittecoq, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 14, 2011
Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantationT M Antonini, M Sebagh, A M Roque-Afonso, et al.
The Journal of Hospital Infection|February 27, 2017
Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?B Davido, R Batista, H Michelon, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Vox Sanguinis|January 1, 1997
Virological and immunological data of AIDS patients treated by passive immunotherapy (transfusions of plasma rich in HIV-1 antibodies)L Morand-Joubert, D Vittecoq, F Roudot-Thoraval, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2000
The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues. Study of Protease Inhibitor Combinations in EuropeG Moyle, A Pozniak, M Opravil, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 4, 2015
Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipientsB Wyplosz, O Derradji, E Hong, et al.
Medecine Et Maladies Infectieuses|December 30, 2008
[Vaccinations for the traveling adult solid organ transplant recipient (excluding hematopoietic stem cell transplant recipients)]B Wyplosz, D Van der Vliet, P H Consigny, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2000
Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipientP Sellier, J J Monsuez, C Lacroix, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 10, 2013
Persistence of yellow fever vaccine-induced antibodies after solid organ transplantationB Wyplosz, C Burdet, H François, et al.
The Journal of Hospital Infection|February 26, 2018
Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative studyA Dinh, H Fessi, C Duran, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 21, 2015
Infectious complications after liver transplantation in human immunodeficiency virus-infected recipientsE Teicher, F Boufassa, D Vittecoq, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 14, 2011
Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantationT M Antonini, M Sebagh, A M Roque-Afonso, et al.
The Journal of Hospital Infection|February 27, 2017
Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?B Davido, R Batista, H Michelon, et al.
Pageof 12